Session Information

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer in Singapore


    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1597

    All times listed are in Singapore time (GMT+8)

    PL - Plenary
    PS - Presidential Symposium
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    IS - Industry Symposium
    JICC - Joint IASLC-CAALC-CSCO Session

Filter Results:

Show Only CME Accredited Sessions

  • +

    P31 - Palliative and Supportive Care - Case Report

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Palliative and Supportive Care
    • +

      P31.01 - A False Alarm of COVID-19 Pneumonia in Lung Cancer: A Case Report of Anti-PD-1 Related Pneumonitis

      00:00 - 00:00  |  Presenter: Ying Dai

      • Abstract

      Loading...

  • +

    P32 - Palliative and Supportive Care - Misc. Topics

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Palliative and Supportive Care
    • +

      P32.01 - Effect of Refined Nursing on Postoperative Early Ambulation in Patients with Thoracoscopic Surgery for Lung Cancer

      00:00 - 00:00  |  Presenter: heling Zhou

      • Abstract

      Loading...

    • +

      P32.02 - Cohort Study of Rehabilitation Quality in Patients With U-VATS and M-VATS Lobectomy

      00:00 - 00:00  |  Presenter: Xiaoqin Liu

      • Abstract

      Loading...

    • +

      P32.03 - Comparison of Two Nursing Effects in Patients With NSCLC Within 2 Hours After General Anesthesia

      00:00 - 00:00  |  Presenter: Yuanyong Wang

      • Abstract

      Loading...

    • +

      P32.04 - Preoperative Self-Reported Symptom Burden and Quality of Life of Patients Undergoing Lung Cancer Surgery: A Cross-Sectional Study

      00:00 - 00:00  |  Presenter: Wei Dai

      • Abstract

      Loading...

    • +

      P32.05 - Correlation Between Malnutrition Universal Screen Tool Score and Outcomes Following Surgical Treatment of Lung Cancer

      00:00 - 00:00  |  Presenter: Tomoyo Fujiwara

      • Abstract

      Loading...

    • +

      P32.06 - Investigation of the Current Use of Opioid Analgesics After Lung Resection and the Analysis of Its Influencing Factors

      00:00 - 00:00  |  Presenter: yuanqiang Zhang

      • Abstract

      Loading...

    • +

      P32.07 - Shortness of Breath in Patients After Thoracomy: A Pilot Study

      00:00 - 00:00  |  Presenter: Guangqiang Shao

      • Abstract

      Loading...

    • +

      P32.08 - Chest Pain After Thoracomy: A Prospective Pilot Study

      00:00 - 00:00  |  Presenter: Guangqiang Shao

      • Abstract

      Loading...

  • +

    P33 - Pathology - Immunotherapy Biomarker

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      P33.01 - Circulating Extracellular Vesicles as Biomarkers for Immune-Checkpoint Inhibitors in Advanced NSCLC

      00:00 - 00:00  |  Presenter: Diego Signorelli

      • Abstract

      Loading...

    • +

      P33.02 - Comparison of PD-L1 Protein Expression Between Primary and Metastatic Lesions in Lung Cancer Patients

      00:00 - 00:00  |  Presenter: Myrto Moutafi

      • Abstract

      Loading...

    • +

      P33.03 - Alteration of Circulating Blood Lymphocyte Subtypes Reveal Therapy Effect in Non-small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: LIANGLIANG XU

      • Abstract

      Loading...

    • +

      P33.04 - Programmed Death-Ligand 1 (PD-L1) Changes in Non-Small-Cell Lung Cancer (NSCLC): Clinical, Pathologic, and Genomic Correlates

      00:00 - 00:00  |  Presenter: Stephanie L. Alden

      • Abstract

      Loading...

    • +

      P33.05 - Identifying Biomarkers of Immune Signature Related to Smoking and Overall Survival in NSCLC on Gene Co-Expression Network

      00:00 - 00:00  |  Presenter: Kunsong Li

      • Abstract

      Loading...

    • +

      P33.06 - Utilizing Serum Proteome to Understand Response and Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Won Kyung Hur

      • Abstract

      Loading...

    • +

      P33.07 - Peripheral CD4+ T cell Signatures in Predicting Response to Anti-PD-1 Monotherapy for Chinese Advanced Non-Small Cell Lung Cancer Patients

      00:00 - 00:00  |  Presenter: Ying Wang

      • Abstract

      Loading...

    • +

      P33.08 - Granulocyte Colony-Stimulating Factor-Producing Lung Cancer With Highly Expresses PD-L1 Protein Expression Level.

      00:00 - 00:00  |  Presenter: Kazuhito Miyazaki

      • Abstract

      Loading...

    • +

      P33.09 - Tumor Mutational Burden in Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy: Outcomes in a Multiethnic Cohort

      00:00 - 00:00  |  Presenter: Laura Sofia Munoz-Arcos

      • Abstract

      Loading...

    • +

      P33.10 - Identification of Long-Responders and Fast-Progressors under Immunotherapy Based on Early Monitoring of dNLR in Advanced NSCLC Patients

      00:00 - 00:00  |  Presenter: Mariona Riudavets

      • Abstract

      Loading...

    • +

      P33.11 - Immunotherapy Outcomes in KRAS Mutated vs KRAS Wild-Type Advanced Lung Adenocarcinoma

      00:00 - 00:00  |  Presenter: Danielle Collons

      • Abstract

      Loading...

    • +

      P33.12 - Real-World Prevalence of PD-L1 Expression in Chinese Patients with Advanced or Metastatic NSCLC: Express II Study

      00:00 - 00:00  |  Presenter: Dong-Mei Lin

      • Abstract

      Loading...

    • +

      P33.13 - Prognostic and Predictive Value of Complete Blood Count Parameters in Patients with NSCLC Treated with PD-1 Inhibitors

      00:00 - 00:00  |  Presenter: Ioannis Tourkantonis

      • Abstract

      Loading...

    • +

      P33.14 - STK11/LKB1, KRAS Mutations and Immune-Related Adverse Events as Predictors of Response to Immunotherapy in Lung Cancer

      00:00 - 00:00  |  Presenter: Luis E. Raez

      • Abstract

      Loading...

    • +

      P33.15 - TMB in the First-Line Setting of NSCLC: A Systematic Review with Indirect Comparisons Between PD-1 and PD-L1 Inhibitors

      00:00 - 00:00  |  Presenter: VALERIO Gristina

      • Abstract

      Loading...

    • +

      P33.16 - Relationship Between PD-L1 Expression and FDG-PET Imaging in Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Ken Onodera

      • Abstract

      Loading...

    • +

      P33.17 - Incidence of PD-L1 Expression at Clinically Significant Cut Offs in NSCLC EGFR Mutated Population Compared to Wild Type

      00:00 - 00:00  |  Presenter: Barbara Melosky

      • Abstract

      Loading...

    • +

      P33.18 - The Prevalence of PDL-1 Expression in Lung Cancer: Real-World Experience from a Tertiary Care Oncology Centre

      00:00 - 00:00  |  Presenter: Rajiv Kumar

      • Abstract

      Loading...

    • +

      P33.19 - Association Between Expression of Immune Response-Related Genes and Response to Nivolumab in Metastatic Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Augusto Obuti Saito

      • Abstract

      Loading...

    • +

      P33.20 - Evaluation of Combined Biomarker of Response to Immunotherapy in Patients with Advanced Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Hayat Oum El Kheir Ramdani

      • Abstract

      Loading...

    • +

      P33.21 - Epidemiological Characteristics and Survival in Patients With Lung Cancer in a Peruvian Private Institution Between 2011-2014

      00:00 - 00:00  |  Presenter: Jose Maria Gutierrez

      • Abstract

      Loading...

    • +

      P33.23 - Tumor Infiltrating Immune Cells Predict Clinical Outcome after Immune Checkpoint Inhibitor Therapy in NSCLC 

      00:00 - 00:00  |  Presenter: Guojie Lu

      • Abstract

      Loading...

  • +

    P34 - Pathology - Liquid Biopsy

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      P34.01 - Utility of Assessment of the EGFR Resistance Genotype using Cell-Free DNA and CTCs from Liquid Biopsies  

      00:00 - 00:00  |  Presenter: Martin P Barr

      • Abstract

      Loading...

    • +

      P34.02 - Detection of PD-L1 Expression and Its Clinical Significance in Circulating Tumor Cells From Patients With Non-Small-Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Yuxin Cheng

      • Abstract

      Loading...

    • +

      P34.03 - A ‘Plasma-First’ Molecular Profiling Approach Complements Actionable Mutation Detection in Suspected Lung Cancer Patients

      00:00 - 00:00  |  Presenter: Jamie Mong

      • Abstract

      Loading...

    • +

      P34.04 - Circulating Tumor DNA (ctDNA) as a Marker of Progressive Disease in Patients with Advanced Lung Cancer 

      00:00 - 00:00  |  Presenter: Bryan C Ulrich

      • Abstract

      Loading...

    • +

      P34.05 - Perioperative Driver Mutation Detection in Circulating Tumor DNA from Lung Cancer Patients across Multiple Timepoints

      00:00 - 00:00  |  Presenter: Yue Pu

      • Abstract

      Loading...

    • +

      P34.06 - The Clinical Utility of Liquid Biopsy by Digital Droplet PCR in Patients with Advanced NSCLC

      00:00 - 00:00  |  Presenter: Virginie Jeanine Lamberts

      • Abstract

      Loading...

    • +

      P34.07 - Quantification of BIM mRNA In Circulating Tumor Cells Of Osimertinib-treated Patients with EGFR Mutation-positive Lung Cancer

      00:00 - 00:00  |  Presenter: Kazutoshi Isobe

      • Abstract

      Loading...

    • +

      P34.08 - Circulating Tumor Cell as a Predictive Marker for Immunotherapy in Advanced Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Cheol-Kyu Park

      • Abstract

      Loading...

    • +

      P34.09 - The Dynamic Changes of ctDNA and cfDNA in the Perioperative Period of Early NSCLC have the Potential to Predict the Risk of Recurrence

      00:00 - 00:00  |  Presenter: Zheng Ma

      • Abstract

      Loading...

    • +

      P34.10 - Transformation to Small Cell Lung Cancer from an Adenocarcionma EGFR+ as Resistance Mechanism. Utility of Liquid Biopsy in Treatment Selection

      00:00 - 00:00  |  Presenter: Miguel Muñoz

      • Abstract

      Loading...

  • +

    P35 - Pathology - Genomics

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      P35.01 - Genomic Origin and Immune-related Status of Pulmonary Sarcomatoid Carcinoma

      00:00 - 00:00  |  Presenter: Likun Chen

      • Abstract

      Loading...

    • +

      P35.02 - Lung Adenocarcinoma with Oncogenic SMARCA4 Mutation: Possible Target of Cancer Immunotherapy

      00:00 - 00:00  |  Presenter: Hee Sang Hwang

      • Abstract

      Loading...

    • +

      P35.03 - Methylation Signatures Associated with T790M Status in Progressive NSCLC

      00:00 - 00:00  |  Presenter: Grainne O'Kane

      • Abstract

      Loading...

    • +

      P35.04 - The Prognostic Value of Metastasis to Different Organs in EGFR-Mutated Stage IV NSCLC Patients Treated with First-Line Icotinib

      00:00 - 00:00  |  Presenter: Yudong Wang

      • Abstract

      Loading...

    • +

      P35.05 - The Monitoring of Mutated EGFR Levels in Liquid Biopsy from Patients on EGFR-TKIs – Early Detection of NSCLC Progression

      00:00 - 00:00  |  Presenter: Joanna Chorostowska-Wynimko

      • Abstract

      Loading...

    • +

      P35.06 - The Biomarkers of Radiation Pneumonia in NSCLC Were Based on Serum Proteomic Changes

      00:00 - 00:00  |  Presenter: jiancheng Li

      • Abstract

      Loading...

    • +

      P35.07 - Analysis of Inter-Tumor Heterogeneity Among Lesions in Autopsy Cases With Untreated Lung Cancer by DNA Methylation Profiling

      00:00 - 00:00  |  Presenter: Hiroaki Harada

      • Abstract

      Loading...

    • +

      P35.08 - RNA-Based Gene Alteration and Expression Analysis in Sq-NSCLC with known FGFR1 Amplification and Protein Expression Status

      00:00 - 00:00  |  Presenter: Joanna Chorostowska-Wynimko

      • Abstract

      Loading...

    • +

      P35.09 - Oncogenetic Differences in Never-Smokers versus Smokers with NSCLC Adenocarcinoma Treated at the Mt Sinai Tisch Cancer Institute

      00:00 - 00:00  |  Presenter: Philip Christopher Mack

      • Abstract

      Loading...

    • +

      P35.10 - Concomitant Driver Gene Mutations in Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Jianping Wang

      • Abstract

      Loading...

    • +

      P35.11 - Molecular Profiling Can Distinguish Multiple Lung Primary Tumors From Intrapulmonary Metastases

      00:00 - 00:00  |  Presenter: Wei Cheng

      • Abstract

      Loading...

    • +

      P35.12 - Assessment of Molecular Heterogeneity in Multiple Primary Lung Cancer Patients by Whole-Exome Sequencing

      00:00 - 00:00  |  Presenter: Lizhu Lin

      • Abstract

      Loading...

    • +

      P35.14 - NGS-Based Molecular Profiling of ‘Quadruple-Negative’ (EGFR/KRAS/ALK/ROS1) Advanced Non-Small-Cell Lung Cancer (aNSCLC).

      00:00 - 00:00  |  Presenter: Sara Pilotto

      • Abstract

      Loading...

    • +

      P35.15 - Molecular Epidemiology of KRAS G12C Mutations in Chinese Lung Cancer Patients

      00:00 - 00:00  |  Presenter: Herbert H Loong

      • Abstract

      Loading...

    • +

      P35.16 - Biomarker Landscape in Multicenter China Lung Cancer Precision Medicine Registry

      00:00 - 00:00  |  Presenter: Jinbo Wu

      • Abstract

      Loading...

    • +

      P35.17 - Novel Genetic Characteristics in Low-Grade Fetal Adenocarcinoma of the Lung

      00:00 - 00:00  |  Presenter: Shuyang Zhang

      • Abstract

      Loading...

    • +

      P35.18 - Genomic Alteration Profiles in Rare Types of Lung Cancer

      00:00 - 00:00  |  Presenter: Jirapath Wiwitkeyoonwong

      • Abstract

      Loading...

    • +

      P35.19 - The Mutational Landscape in South Asian Patients with Non-Small Cell Lung Cancer at an US Academic Medical Center

      00:00 - 00:00  |  Presenter: Mohana Roy

      • Abstract

      Loading...

    • +

      P35.20 - Genomic Profiling and PD-L1 Expression Association Analysis in Epstein-Barr Virus (EBV)-infected Lung Cancer Patients

      00:00 - 00:00  |  Presenter: Xiahui Yang

      • Abstract

      Loading...

    • +

      P35.21 - Comprehensive Genomic Profiling of Lung Metastases in Cancer Patients

      00:00 - 00:00  |  Presenter: Li Wang

      • Abstract

      Loading...

    • +

      P35.23 - Integrated Analysis of Genomic and Immunological Features in Lung Adenocarcinoma with Micropapillary Component

      00:00 - 00:00  |  Presenter: Yang Xu

      • Abstract

      Loading...

    • +

      P35.24 - Evaluation of an Up-To-Date Knowledge Base to Aid in Interpreting Somatic Mutations Detected in NGS Testing of Lung Cancer

      00:00 - 00:00  |  Presenter: Stephanie J. Yaung

      • Abstract

      Loading...

    • +

      P35.26 - Comparative Genomic Profiling of Lung Adenocarcinoma in Self-Reported Asian and White Patients, a Propensity Matched Study of 1400 Samples

      00:00 - 00:00  |  Presenter: Jian Zhou

      • Abstract

      Loading...

    • +

      P35.27 - Next Generation Sequencing Reveals the Genetic Landscape of JAK Family in Chinese Lung Cancer Patients

      00:00 - 00:00  |  Presenter: Lin Gui

      • Abstract

      Loading...

    • +

      P35.29 - The Genomic Landscape of Lung Cancer Patients Highlights Age-Dependent Mutation Frequencies and Clinical Actionability in Young Patients

      00:00 - 00:00  |  Presenter: Xiaoling Tong

      • Abstract

      Loading...

  • +

    P36 - Pathology - Prognosis

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      P36.01 - KEAP1 and NRF2 Mutations in Hispanic and Non-Hispanic Patients with NSCLC: Clinicopathologic Characteristics and Prognosis.

      00:00 - 00:00  |  Presenter: Khadeja Khan

      • Abstract

      Loading...

    • +

      P36.02 - CHEK1: Unfavourable Prognostic Hub Gene and Potential Therapeutic Target for Lung Adenocarcinoma

      00:00 - 00:00  |  Presenter: 谭 Tan

      • Abstract

      Loading...

    • +

      P36.03 - Identification of Immune-Related lncRNA Clusters and Prognostic Effects for Lung Adenocarcinoma Patients

      00:00 - 00:00  |  Presenter: Haiyong Wang

      • Abstract

      Loading...

    • +

      P36.04 - Molecular Prognostic Factors in Neuroendocrine Thymic Tumors: a Retrospective Multicentre Study

      00:00 - 00:00  |  Presenter: Niccolò Daddi

      • Abstract

      Loading...

    • +

      P36.05 - Metastatic NSCLC Outcomes With Guideline-Recommended Treatment By KRAS Subtype

      00:00 - 00:00  |  Presenter: Anifat Elegbede

      • Abstract

      Loading...

    • +

      P36.06 - The Association Between Prognostic Value and Mutations in TGF-β Signaling Pathway in Small Cell Lung Cancer Patients

      00:00 - 00:00  |  Presenter: Qing Bu

      • Abstract

      Loading...

    • +

      P36.07 - Pleckstrin Homology-Like (PHLDA) Domain Family Members Immunoexpression as Prognostic Marker in Lung Cancer and Mesothelioma

      00:00 - 00:00  |  Presenter: Camila Machado Baldavira

      • Abstract

      Loading...

    • +

      P36.08 - Effect of Soluble CD39 and PD-L1 Levels on Diagnosis and Prognosis of Lung Cancer Patients with Malignant Pleural Effusion

      00:00 - 00:00  |  Presenter: Tangfeng Lv

      • Abstract

      Loading...

    • +

      P36.09 - Overexpression of KIAA0101 Promotes the Progression of Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: He Cao

      • Abstract

      Loading...

    • +

      P36.10 - Prognostic Value and Transcriptional Expression Profile of GINS Family Members in Lung Adenocarcinoma

      00:00 - 00:00  |  Presenter: Fangyan Zhong

      • Abstract

      Loading...

    • +

      P36.11 - Clinicopathological Features of Long-Term Survivors in Lung Cancer

      00:00 - 00:00  |  Presenter: Ioannis Tourkantonis

      • Abstract

      Loading...

  • +

    P37 - Pathology - Biomarker Testing

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      P37.01 - Detection of NTRK Rearrangements by Next-Generation Sequencing in Chinese Lung Carcinoma Patients

      00:00 - 00:00  |  Presenter: Ming Wu

      • Abstract

      Loading...

    • +

      P37.02 - Identification of Gene Fusions and Mutations in Patients with NSCLC using two Diagnostic Approaches: Rapid qPCR and NGS

      00:00 - 00:00  |  Presenter: Andrzej Tysarowski

      • Abstract

      Loading...

    • +

      P37.03 - Analysis of Drug-Induced RNA Expression Changes in NSCLC Patient-Derived Explants as a Potential Tool for Personalized Therapy Choice

      00:00 - 00:00  |  Presenter: Evgeny Imyanitov

      • Abstract

      Loading...

    • +

      P37.04 - EGFR Mutations in US Hispanics with Lung Adenocarcinoma are Common and Portend a Worse Prognosis

      00:00 - 00:00  |  Presenter: Jonathan Villena-Vargas

      • Abstract

      Loading...

    • +

      P37.05 - Prognostic Characteristics and Immunotherapy Response of Non-Squamous NSCLC Patients with KRAS Mutation in East Asian Populations

      00:00 - 00:00  |  Presenter: Shang-Gin Wu

      • Abstract

      Loading...

    • +

      P37.06 - Are all ALK Gene Rearrangements Created Equal??

      00:00 - 00:00  |  Presenter: Ullas Batra

      • Abstract

      Loading...

    • +

      P37.07 - Discordance on Repeat PD-L1 Testing in Non-Small Cell Lung Carcinoma

      00:00 - 00:00  |  Presenter: Julia R Naso

      • Abstract

      Loading...

    • +

      P37.08 - OncomineTM Dx Target Test Companion Diagnostic System for Advanced Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Fumiyoshi Ohyanagi

      • Abstract

      Loading...

    • +

      P37.09 - Comparison of 3 Different Methods for Determination of EGFR p.Thr790Met mutation in patients with NSCLC

      00:00 - 00:00  |  Presenter: Andrzej Tysarowski

      • Abstract

      Loading...

    • +

      P37.10 - PD-L1 Expression in Lymphovascular Tumor Emboli in Lung Adenocarcinoma

      00:00 - 00:00  |  Presenter: Yi-Chen Yeh

      • Abstract

      Loading...

    • +

      P37.11 - Assessment of Plasma D-Dimer as a Predictive Biomarker for Treatment Response in Lung Cancer Treated with Radiation Therapy

      00:00 - 00:00  |  Presenter: Abhirup Chanda

      • Abstract

      Loading...

    • +

      P37.12 - Concordance of Next-Generation Sequencing Between Tissue and Liquid Biopsies in Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Fahmin Basher

      • Abstract

      Loading...

    • +

      P37.13 - Diagnostic Performance of Aptamer-Based Multiplex PCR Compared to Luminex Assay for Detection of Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Yunha Nam

      • Abstract

      Loading...

    • +

      P37.14 - Comparative Evaluation of IHC versus FISH for Detection of ROS1 Fusion in Lung Cancer

      00:00 - 00:00  |  Presenter: Rajiv Kumar

      • Abstract

      Loading...

    • +

      P37.15 - Prevalence of Targetable Mutations using a RT-qPCR Multiplex Assay in Asian NSCLC Patients: A Single Laboratory Experience

      00:00 - 00:00  |  Presenter: Shi Feng Nyaw

      • Abstract

      Loading...

    • +

      P37.16 - Alterations in HRR Related Genes as Potential Markers of Clinical Benefit from PARP Inhibitor and PD-1/PD-L1 Blockade in Advanced Lung Cancer

      00:00 - 00:00  |  Presenter: yu Lei

      • Abstract

      Loading...

    • +

      P37.17 - Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutations in Non-small Cell Lung Cancer (NSCLC): A Global Meta-analysis

      00:00 - 00:00  |  Presenter: Barbara Melosky

      • Abstract

      Loading...

    • +

      P37.18 - Lung NSCLC Molecular Diagnostic Comparison Between NGS and Multiplex PCR Assays

      00:00 - 00:00  |  Presenter: Kiat Hon Tony Lim

      • Abstract

      Loading...

    • +

      P37.19 - Activin-A and GDF-11 as Predictive Biomarkers for Platinum Response in Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Jennifer Wen Ying Lim

      • Abstract

      Loading...

    • +

      P37.20 - Diagnostic EGFR Mutations in Non Small Cell Lung Cancer With Specimens of Body Cavity Fluids

      00:00 - 00:00  |  Presenter: Nguyen Son Lam

      • Abstract

      Loading...

    • +

      P37.21 - Improvement of PCR-Based Detection of ALK Rearrangements

      00:00 - 00:00  |  Presenter: Evgeny Imyanitov

      • Abstract

      Loading...

    • +

      P37.22 - Unique Characterization of KRAS Mutation in Non-Small Cell Lung Cancer in Thai Population

      00:00 - 00:00  |  Presenter: Narumol Trachu

      • Abstract

      Loading...

    • +

      P37.23 - Real-World PD-L1 Expression in Lung Cancer and its Correlation with Driver Mutations

      00:00 - 00:00  |  Presenter: Tao Wang

      • Abstract

      Loading...

    • +

      P37.24 - Identification of microRNAs in Non-Small-Cell Lung Cancer Based on Bioinformation Analysis

      00:00 - 00:00  |  Presenter: lulu Feng

      • Abstract

      Loading...

    • +

      P37.25 - Clinical Validation of Low-costs Next Generation Sequencing Panels in Solid Tumors

      00:00 - 00:00  |  Presenter: Yen-Lin Chen

      • Abstract

      Loading...

    • +

      P37.26 - Comprehensive Comparison of 22C3 and SP263 PD-L1 Expression using Routine Clinical and Conditioned Archives of Non-Small-Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Tae Jung Kim

      • Abstract

      Loading...

    • +

      P37.27 - Epidemiology of EGFR Positive Adenocarcinoma NSCLC From India: A Systematic Review and Meta-analysis

      00:00 - 00:00

      • Abstract

      Loading...

    • +

      P37.29 - Clinical Characteristics that Affect the Success Rate of BRAF-V600E Oncomine Dx Target Test

      00:00 - 00:00  |  Presenter: Yuki Sato

      • Abstract

      Loading...

    • +

      P37.30 - Prevalence of Actionable Mutations among Indian Patients with Advanced Non-Small Cell Lung Cancer: A Systematic Review

      00:00 - 00:00  |  Presenter: Ruchir Raman

      • Abstract

      Loading...

    • +

      P37.31 - Trends in the Detection of EGFR Exon 20 Insertions in Patients with NSCLC in the US

      00:00 - 00:00  |  Presenter: Huamao M Lin

      • Abstract

      Loading...

    • +

      P37.32 - Epigenetic Imprinted Genes as Biomarkers for the Proactive Detection and Accurate Presurgical Diagnosis of Small Lung Nodules

      00:00 - 00:00  |  Presenter: Ning Zhou

      • Abstract

      Loading...

    • +

      P37.33 - A look at EGFR, ALK, and PD-L1 Biomarker Test Availability, Adoption, and Test Ordering Behavior at Diagnosis of NSCLC in the United States

      00:00 - 00:00  |  Presenter: Jirawas Sornkom

      • Abstract

      Loading...

    • +

      P37.34 - Outcome Associations with p16, GATA-3, and TTF-1 Clone SP141 IHC Expression in Resected Stage I Lung Squamous Cell Carcinomas

      00:00 - 00:00  |  Presenter: Artem Shevtsov

      • Abstract

      Loading...

    • +

      P37.35 - Identification of DNA Methylation Markers to Distinguish Early-Stage Lung Adenocarcinomas from Benign Pulmonary Nodules

      00:00 - 00:00  |  Presenter: Feilong Zhao

      • Abstract

      Loading...

  • +

    P38 - Pathology - Pathology/Staging

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      P38.01 - The Role of Pathology in The Proposed Subdivided N Descriptors of The TNM Staging System For Lung Cancer– A Single Center Experience

      00:00 - 00:00  |  Presenter: Pınar Bulutay

      • Abstract

      Loading...

    • +

      P38.02 - Reproducibility and Accuracy of Intra-Operative Assessment on Tumor Spread Through Air Spaces in Stage 1 Lung Adenocarcinomas

      00:00 - 00:00  |  Presenter: Julian A. Villalba

      • Abstract

      Loading...

    • +

      P38.03 - Immunohistochemical, Histologic and Genomic Characterisation of Early Stage Pulmonary Invasive Mucinous Adenocarcinoma

      00:00 - 00:00  |  Presenter: Aaron C Tan

      • Abstract

      Loading...

    • +

      P38.04 - 3D Analysis of Spread Through Air Spaces in Squamous Cell Carcinoma and Carcinoid Tumor Using Whole Block Imaging by Micro CT

      00:00 - 00:00  |  Presenter: Takashi Inoue

      • Abstract

      Loading...

    • +

      P38.05 - Clinical, Genetic, Radiological, and Pathological Characteristics of Cribriform Adenocarcinoma of the Lung

      00:00 - 00:00  |  Presenter: Akihiko Yoshizawa

      • Abstract

      Loading...

    • +

      P38.06 - Evaluation of Non-invasive Transcutaneous Bioconductance Measurement - a Risk-Stratification Biomarker for Suspicious Pulmonary Lesions

      00:00 - 00:00  |  Presenter: Dawei Yang

      • Abstract

      Loading...

    • +

      P38.07 - Comprehensive Investigation of Mutational Features of Various Lung Adenocarcinoma Histological Subtypes Among Chinese Patients

      00:00 - 00:00  |  Presenter: Yuchen Han

      • Abstract

      Loading...

    • +

      P38.08 - Clinical Features and Survival Risk Factors of Lung Lymphoepithelioma-Like Carcinoma Based on the SEER Database Analysis

      00:00 - 00:00  |  Presenter: Chun-wei Xu

      • Abstract

      Loading...

    • +

      P38.09 - Clinicopathological Characteristics of Combined Small-Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Yuko Iida

      • Abstract

      Loading...

    • +

      P38.10 - Relationship Between the Diffusing Capacity of the Lung for Carbon Monoxide (DLCO) and Lung Adenocarcinoma Patterns: A Single-Center Experience

      00:00 - 00:00  |  Presenter: Luigi Ventura

      • Abstract

      Loading...

    • +

      P38.11 - Clinical and Molecular Characteristics of TSC1/2 Mutant Lung Cancer

      00:00 - 00:00  |  Presenter: Yanye Wang

      • Abstract

      Loading...

    • +

      P38.12 - Lung Adenocarcinoma with Sarcomatoid Transformation after Tyrosine Kinase Inhibitor Treatment and Chemotherapy

      00:00 - 00:00

      • Abstract

      Loading...

    • +

      P38.13 - Cytology-Histology Concordance for Diagnosis, Histological Subtyping and Molecular Profiling of Lung Cancer

      00:00 - 00:00  |  Presenter: Ioannis Tourkantonis

      • Abstract

      Loading...

    • +

      P38.14 - Demographic and Molecular Epidemiologic Profile of Primary Lung Cancer in Eastern India

      00:00 - 00:00  |  Presenter: Satya Mantha Padmaja

      • Abstract

      Loading...

    • +

      P38.15 - Interactive Genes Between Tumor Immune Microenvironment and Epithelial-Mesenchymal Transition During Lung Cancer Metastasis

      00:00 - 00:00  |  Presenter: Jie Ma

      • Abstract

      Loading...

    • +

      P38.16 - Expression of ROS1 Gene Rearrangement in Pulmonary Inflammatory Myofibroblastic Tumor With Cerebral Metastasis: Case Report  

      00:00 - 00:00  |  Presenter: IHSAN Alloubi

      • Abstract

      Loading...

    • +

      P38.17 - Pulmonary Small Cell Carcinoma with Rhabdomyoblastic Differentiation: A Previously Unreported Occurrence

      00:00 - 00:00  |  Presenter: Jasper Johar

      • Abstract

      Loading...

    • +

      P38.18 - A Rare Case of Pleomorphic Carcinoma Arising in Adulthood Type 1 Congenital Pulmonary Airway Malformation

      00:00 - 00:00  |  Presenter: Niccolò Daddi

      • Abstract

      Loading...

    • +

      P38.19 - Lung Cancer in Young Adults: A Two-Center, Retrospective Study of the Clinical and Pathological Characteristics

      00:00 - 00:00  |  Presenter: Mora Guardamagna

      • Abstract

      Loading...

  • +

    P39 - Patient Advocacy

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Patient Advocacy
    • +

      P39.01 - Satisfaction with the Lung Cancer Care Pathway. Is it time to Revise the way we Monitor and Assess Patient Experience?

      00:00 - 00:00  |  Presenter: Yvonne Nartey

      • Abstract

      Loading...

    • +

      P39.02 - ‘Making Moments Matter’ – A Lung Cancer Campaign from the Marie Keating Foundation

      00:00 - 00:00  |  Presenter: Anne Marie Baird

      • Abstract

      Loading...

    • +

      P39.03 - Developing A Collaborative Northern Roadmap for Lung Cancer Care

      00:00 - 00:00  |  Presenter: Carolyn Roberts

      • Abstract

      Loading...

    • +

      P39.04 - ALK Positive UK: 42% of UK Patients do not Receive Regular Brain MRI Scans Despite Data Showing up to 70% of Patients Develop Brain Metastases

      00:00 - 00:00  |  Presenter: Debra Montague

      • Abstract

      Loading...

    • +

      P39.05 - Access Disparities and Challenges in Lung Cancer Diagnostics and Treatment – A European Perspective

      00:00 - 00:00  |  Presenter: Anne Marie Baird

      • Abstract

      Loading...

    • +

      P39.06 - Surviving Metastatic Non-Small Cell Lung Cancer – Experience and Supportive Care Needs of Patients Receiving Novel Therapies 

      00:00 - 00:00  |  Presenter: Sarah Ellen Heynemann

      • Abstract

      Loading...

    • +

      P39.07 - Evaluating the Success of the First Global Lung Cancer Coalition Patient Experience Survey

      00:00 - 00:00  |  Presenter: Vanessa Beattie

      • Abstract

      Loading...

    • +

      P39.08 - The Effect of COVID-19 on Anxiety in Canadian Lung Cancer Patients

      00:00 - 00:00  |  Presenter: Christina Sit

      • Abstract

      Loading...

    • +

      P39.09 - Social Media Support of Lung Cancer Patient Associations During the Lockdown Restrictions in Italy: A Breath of Life During the COVID-19 Pandemic.

      00:00 - 00:00  |  Presenter: Tindara Franchina

      • Abstract

      Loading...

  • +

    P40 - Risk Reduction and Tobacco Control

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Risk Reduction and Tobacco Control
    • +

      P40.01 - Tobacco use in Adolescence and Associated Factors: Products, School, Family, Peers and Movies in Pandemic Period

      00:00 - 00:00  |  Presenter: Domenico Galetta

      • Abstract

      Loading...

    • +

      P40.02 - Female Lung Cancer: An Emerging Issue in Bangladesh

      00:00 - 00:00  |  Presenter: Nausheen Hakim

      • Abstract

      Loading...

    • +

      P40.03 - Report on a Phytochemical-rich Dietary Intervention Trial to Prevent Lung Cancer: Implementation in a High-Risk Lung Screening Clinic

      00:00 - 00:00  |  Presenter: Marisa Bittoni

      • Abstract

      Loading...

    • +

      P40.04 - Knowledge, Attitudes and Perception of Lung Cancer Screening Among Smoking Soft-Ware Professionals in India

      00:00 - 00:00  |  Presenter: Venkata pradeep babu Koyyala

      • Abstract

      Loading...

    • +

      P40.05 - Current Status of a Smoking Cessation Supportive Program on Nurses' Interventions: A Single Institutional Experience

      00:00 - 00:00  |  Presenter: Reiko Kori

      • Abstract

      Loading...